Cargando…
Real‐life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial)
BACKGROUND: This study aimed to describe the treatment strategies and outcomes for women with newly diagnosed advanced high‐grade serous or endometrioid ovarian cancer (OC). METHODS: This observational study collected real‐world medical record data from eight Western countries on the diagnostic work...
Autores principales: | Marth, Christian, Abreu, Miguel Henriques, Andersen, Klaus Kaae, Aro, Karoliina M., de Lurdes Batarda, Maria, Boll, Dorry, Ekmann‐Gade, Anne Weng, Haltia, Ulla‐Maija, Hansen, Jesper, Haug, Ala Jabri, Høgdall, Claus, Korach, Jacob, Lassus, Heini, Lindemann, Kristina, Van Nieuwenhuysen, Els, Ottevanger, Petronella B., Polterauer, Stephan, Schnack, Tine Henrichsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545328/ https://www.ncbi.nlm.nih.gov/pubmed/35714310 http://dx.doi.org/10.1002/cncr.34350 |
Ejemplares similares
-
The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis
por: Ingerslev, Kasper, et al.
Publicado: (2017) -
The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019) -
High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
por: Ingerslev, Kasper, et al.
Publicado: (2016) -
Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022) -
Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022)